Toll Free: 1-888-928-9744
Published: Jul, 2014 | Pages:
41 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)
Sinovac Biotech Ltd. - Product Pipeline Review - 2014 Summary Global Markets Direct's, 'Sinovac Biotech Ltd. - Product Pipeline Review - 2014', provides an overview of the Sinovac Biotech Ltd.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sinovac Biotech Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides brief overview of Sinovac Biotech Ltd. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Sinovac Biotech Ltd.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Sinovac Biotech Ltd.'s pipeline products Reasons to buy - Evaluate Sinovac Biotech Ltd.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Sinovac Biotech Ltd. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Sinovac Biotech Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Sinovac Biotech Ltd. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sinovac Biotech Ltd. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Sinovac Biotech Ltd. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Sinovac Biotech Ltd. Snapshot 5 Sinovac Biotech Ltd. Overview 5 Key Information 5 Key Facts 5 Sinovac Biotech Ltd. - Research and Development Overview 6 Key Therapeutic Areas 6 Sinovac Biotech Ltd. - Pipeline Review 9 Pipeline Products by Stage of Development 9 Pipeline Products - Monotherapy 10 Pipeline Products - Combination Treatment Modalities 11 Sinovac Biotech Ltd. - Pipeline Products Glance 12 Sinovac Biotech Ltd. - Late Stage Pipeline Products 12 Pre-Registration Products/Combination Treatment Modalities 12 Sinovac Biotech Ltd. - Clinical Stage Pipeline Products 13 Phase I Products/Combination Treatment Modalities 13 Sinovac Biotech Ltd. - Early Stage Pipeline Products 14 IND/CTA Filed Products/Combination Treatment Modalities 14 Preclinical Products/Combination Treatment Modalities 15 Discovery Products/Combination Treatment Modalities 16 Sinovac Biotech Ltd. - Drug Profiles 17 EV-71 Vaccine 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 Pneumococcal Polysaccharides Vaccine (23-valent) 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 Chickenpox Vaccine 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 Influenza Vaccine [H7N9] 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Pneumococcal Conjugate Vaccine 22 Product Description 22 Mechanism of Action 22 R&D Progress 22 Rubella Vaccine 23 Product Description 23 Mechanism of Action 23 R&D Progress 23 Coxsackievirus Vaccine [A16] 24 Product Description 24 Mechanism of Action 24 R&D Progress 24 Diphtheria + Tetanus + Pertussis (Acellular) Vaccine 25 Product Description 25 Mechanism of Action 25 R&D Progress 25 Hepatitis B Vaccine 26 Product Description 26 Mechanism of Action 26 R&D Progress 26 Hib Vaccine 27 Product Description 27 Mechanism of Action 27 R&D Progress 27 Human Rabies Vaccine 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Meningitis Vaccine 29 Product Description 29 Mechanism of Action 29 R&D Progress 29 Polio Vaccine 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 Rotavirus Vaccine 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 Pandemic Influenza Vaccine 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 Sinovac Biotech Ltd. - Pipeline Analysis 33 Sinovac Biotech Ltd. - Pipeline Products by Route of Administration 33 Sinovac Biotech Ltd. - Pipeline Products by Molecule Type 34 Sinovac Biotech Ltd. - Recent Pipeline Updates 35 Sinovac Biotech Ltd. - Dormant Projects 38 Sinovac Biotech Ltd. - Locations And Subsidiaries 39 Head Office 39 Other Locations & Subsidiaries 39 Appendix 40 Methodology 40 Coverage 40 Secondary Research 40 Primary Research 40 Expert Panel Validation 40 Contact Us 41 Disclaimer 41
List of Tables Sinovac Biotech Ltd., Key Information 5 Sinovac Biotech Ltd., Key Facts 5 Sinovac Biotech Ltd. - Pipeline by Indication, 2014 8 Sinovac Biotech Ltd. - Pipeline by Stage of Development, 2014 9 Sinovac Biotech Ltd. - Monotherapy Products in Pipeline, 2014 10 Sinovac Biotech Ltd. - Combination Treatment Modalities in Pipeline, 2014 11 Sinovac Biotech Ltd. - Pre-Registration, 2014 12 Sinovac Biotech Ltd. - Phase I, 2014 13 Sinovac Biotech Ltd. - IND/CTA Filed, 2014 14 Sinovac Biotech Ltd. - Preclinical, 2014 15 Sinovac Biotech Ltd. - Discovery, 2014 16 Sinovac Biotech Ltd. - Pipeline by Route of Administration, 2014 33 Sinovac Biotech Ltd. - Pipeline by Molecule Type, 2014 34 Sinovac Biotech Ltd. - Recent Pipeline Updates, 2014 35 Sinovac Biotech Ltd. - Dormant Developmental Projects,2014 38 Sinovac Biotech Ltd., Other Locations 39
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.